UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Corestem fails to get insurance benefit for Lou Gehrig’s drug
A state-run health insurance review agency has refused to grant insurance b...
by Song Soo-youn
|
2019-04-26 15:43
라인
Genexine, NeoImmuneTech apply combo treatment to breast cancer
Genexine, NeoImmuneTech have started administering its combination treatmen...
by Lee Han-soo
|
2019-04-26 12:00
라인
GC wins $35.7 million flu vaccine contract from Latin America
GC said Thursday it has secured a $35.7 million contract to supply influenz...
by Lee Han-soo
|
2019-04-25 17:52
라인
Hugel submits new drug application for BTX in China
Hugel has filed a new drug application (NDA) for Botulax, its botulinum tox...
by Lee Han-soo
|
2019-04-25 16:47
라인
FDA OKs AbbVie’s plaque psoriasis treatment
The U.S. Food and Drug Administration approved Skyrizi (Ingredient: risanki...
by Lee Han-soo
|
2019-04-25 15:53
라인
Korean units of Bayer, Fresenius sent largest dividends to parent firms
Among multinational pharmaceuticals’ offshoots operating in the nation, Bay...
by Lee Han-soo
|
2019-04-25 12:02
라인
‘PD-L1 expression poor marker for bladder cancer’s immunotherapy’
More than a year has passed since Tecentriq (atezolizumab), new immunothera...
by Kim Yun-mi
|
2019-04-25 11:52
라인
Daiichi Sankyo Korea to target anticancer market
Daiichi Sankyo Korea said it would expand its business in Kora to anticance...
by Lee Han-soo
|
2019-04-24 15:43
라인
Diarrhea drug Smecta banned for children under 2
The drug authorities have banned the use of dioctahedral smectite-containin...
by Lee Hye-seon
|
2019-04-24 15:42
라인
Medytox to start P3 trials for Medytoxin in treating overactive bladder
Medytox said Wednesday that it would begin Korea’s first phase 3 clinical t...
by Lee Han-soo
|
2019-04-24 14:06
라인
[News Focus] Cholesterol-reducing PCSK9 inhibitors get popular -- cost-effective, too?
PCSK9 inhibitors have become more popular for patients with a high-risk car...
by Kim Yun-mi
|
2019-04-24 12:35
라인
Huons to market Ambio’s peptide treatment
Huons said Tuesday that it would market in Korea the generic peptide treatm...
by Lee Han-soo
|
2019-04-24 10:33
라인
Medytox launches its BTX in Mexico
Medytox said Monday that it has launched Acebloc, the company’s botulinum t...
by Lee Han-soo
|
2019-04-23 17:30
라인
Takeda’s lung cancer drug to get insurance benefit
Takeda’s Alunbrig (ingredient: Brigatinib), an anaplastic lymphoma kinase (...
by Lee Han-soo
|
2019-04-23 11:48
라인
Harvard professor to join OliX Pharmaceuticals’ scientific advisory board
OliX Pharmaceuticals said Monday that Professor Demetrios G. Vavvas, one of...
by Lee Han-soo
|
2019-04-23 11:47
라인
‘Darzalex as another weapon against multiple myeloma’
Janssen Korea’s Darzalex (ingredient: daratumumab) is effective for heavily...
by Park Gi-taek
|
2019-04-19 15:39
라인
Dong-A to export birth control pill to Vietnam
Dong-A Pharmaceutical said Friday it has agreed to export Roman K, a birth ...
by Lee Han-soo
|
2019-04-19 13:41
라인
CJ HealthCare’s new gastric acid blocker K-Cab sold ₩ 1.5 billion in March
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded 1.53 bil...
by Jeong Sae-im
|
2019-04-18 15:27
라인
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’
In the past, HIV and AIDS were known as deadly diseases that could take awa...
by Kim Yun-mi
|
2019-04-18 15:20
라인
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why?
Novartis’ new treatment for macular degeneration might have to fight agains...
by Kim Yun-mi
|
2019-04-18 14:42
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top